Intelligent Bio Solutions Inc. (NASDAQ:INBS) Sees Significant Growth in Short Interest

Intelligent Bio Solutions Inc. (NASDAQ:INBS) was the recipient of a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 454,100 shares, an increase of 17.3% from the February 13th total of 387,100 shares. Approximately 6.8% of the shares of the stock are short sold. Based on an average daily volume of 200,500 shares, the days-to-cover ratio is presently 2.3 days.

Intelligent Bio Solutions Price Performance

NASDAQ INBS opened at $2.09 on Friday. The business has a fifty day moving average price of $1.93 and a 200 day moving average price of $1.70. Intelligent Bio Solutions has a one year low of $1.00 and a one year high of $4.64.

Intelligent Bio Solutions (NASDAQ:INBS) last posted its quarterly earnings data on Thursday, February 13th. The company reported ($0.50) EPS for the quarter. Intelligent Bio Solutions had a negative net margin of 323.79% and a negative return on equity of 146.03%. The firm had revenue of $610 billion during the quarter. On average, equities research analysts expect that Intelligent Bio Solutions will post -1.25 earnings per share for the current fiscal year.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.